Concepedia

Lanju Zhang

LZ

Statistics

Publications

24

Citations

1.4K

H-Index

15

Active since

2001

Affiliations

AbbVie (United States)(Current)

Vertex Pharmaceuticals (United States)

Altimmune (United States)

University of Maryland, Baltimore County

Shandong University

Lanju Zhang is an author at AbbVie (United States) specializing in biostatistics, medicine, and public health.

Publications per year

2001–2024

24

Publications

24

A New Bliss Independence Model to Analyze Drug Combination Data

Wei Zhao, Kris F. Sachsenmeier, Lanju Zhang et al. · SLAS DISCOVERY · 2014 · 327 citations · Full text

Veterinary Medicine, Pharmacology, Dose-response Modeling +14

A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

Roy Fleischmann, Henning Bliddal, Francisco J. Blanco et al. · Arthritis & Rheumatology · 2019 · 211 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Franco Locatelli, Peter Lang, Donna A. Wall et al. · New England Journal of Medicine · 2024 · 186 citations

Medicine, Genetics, Hematology +17

Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes

Lanju Zhang, William F. Rosenberger · Biometrics · 2005 · 112 citations

Public Health, Biostatistics, Experimental Design +15

Response-Adaptive Randomization for Survival Trials: The Parametric Approach

Lanju Zhang, William F. Rosenberger · Journal of the Royal Statistical Society Series C (Applied Statistics) · 2007 · 76 citations · Full text

Public Health, Biostatistics, Experimental Design +16

1–5 of 24